Azd2014
AZD2014 is a selective and potent small molecule inhibitor of the mammalian target of rapamycin (mTOR) kinase. It inhibits both mTOR complexes, mTORC1 and mTORC2, with nanomolar potency. AZD2014 exhibits high selectivity for mTOR over related kinases.
Lab products found in correlation
4 protocols using azd2014
Evaluating Combination Therapy in PDX Models
Detailed Protocols for Molecular Biology Experiments
All cell culture reagents were purchased from Thermofisher Scientific (Gibco™).
Human Embryonic Kidney (HEK293) cells were purchased from ATCC (U.S.A.), certified as mycoplasma (contamination) free. Michigan Cancer Foundation-7 (MCF-7) breast cancer and Chinese Hamster Ovary (CHO) cells were initially purchased from ECACC (UK) and mycoplasma free.
Chemical Compound Acquisition Protocol
Chemical Compound Acquisition Protocol
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!